TC BioPharm (Holdings) plc
TCBPY, TCBWFHealthcare · Healthcare · Non-accelerated filer<br>Emerging growth company · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 20-Fmissed a reporting deadline ↗Apr 30, 2025
- NT 20-Fmissed a reporting deadline ↗Apr 29, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Clinical trials
ClinicalTrials.gov · ongoing · next readout firstInterventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
Material events
SEC Form 8-K · most recent- Director / officer changeJun 28, 2024
- Delisting / listing-standard noticeMay 29, 2024
- Other material eventMay 20, 2024
- Entered a material agreement · Unregistered equity sale · Other material eventMay 8, 2024
- Other material eventMay 6, 2024
- Other material eventApr 4, 2024
- Shareholder voteMar 19, 2024
- Unregistered equity saleMar 18, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.